Structure

Physi-Chem Properties

Molecular Weight:  464.13
Volume:  433.08
LogP:  0.791
LogD:  0.543
LogS:  -4.267
# Rotatable Bonds:  5
TPSA:  175.37
# H-Bond Aceptor:  11
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.351
Synthetic Accessibility Score:  4.064
Fsp3:  0.409
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.447
MDCK Permeability:  2.165410842280835e-05
Pgp-inhibitor:  0.011
Pgp-substrate:  0.926
Human Intestinal Absorption (HIA):  0.395
20% Bioavailability (F20%):  0.002
30% Bioavailability (F30%):  0.988

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.145
Plasma Protein Binding (PPB):  81.57767486572266%
Volume Distribution (VD):  0.625
Pgp-substrate:  15.14267349243164%

ADMET: Metabolism

CYP1A2-inhibitor:  0.047
CYP1A2-substrate:  0.094
CYP2C19-inhibitor:  0.033
CYP2C19-substrate:  0.146
CYP2C9-inhibitor:  0.049
CYP2C9-substrate:  0.455
CYP2D6-inhibitor:  0.295
CYP2D6-substrate:  0.254
CYP3A4-inhibitor:  0.087
CYP3A4-substrate:  0.112

ADMET: Excretion

Clearance (CL):  9.134
Half-life (T1/2):  0.531

ADMET: Toxicity

hERG Blockers:  0.104
Human Hepatotoxicity (H-HT):  0.252
Drug-inuced Liver Injury (DILI):  0.944
AMES Toxicity:  0.501
Rat Oral Acute Toxicity:  0.247
Maximum Recommended Daily Dose:  0.015
Skin Sensitization:  0.665
Carcinogencity:  0.779
Eye Corrosion:  0.003
Eye Irritation:  0.148
Respiratory Toxicity:  0.413

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC236934

Natural Product ID:  NPC236934
Common Name*:   Homoeriodictyol 7-O-Beta-D-Glucopyranoside
IUPAC Name:   (2S)-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one
Synonyms:  
Standard InCHIKey:  KZQCCKUDYVSOLC-YMTXFHFDSA-N
Standard InCHI:  InChI=1S/C22H24O11/c1-30-15-4-9(2-3-11(15)24)14-7-13(26)18-12(25)5-10(6-16(18)32-14)31-22-21(29)20(28)19(27)17(8-23)33-22/h2-6,14,17,19-25,27-29H,7-8H2,1H3/t14-,17+,19+,20-,21+,22+/m0/s1
SMILES:  COc1cc(ccc1O)[C@@H]1CC(=O)c2c(cc(cc2O1)O[C@H]1[C@@H]([C@H]([C@@H]([C@@H](CO)O1)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1086150
PubChem CID:   21629877
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001583] Flavonoid O-glycosides
            • [CHEMONTID:0003533] Flavonoid-7-O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15592 Swertia punctata Species Gentianaceae Eukaryota n.a. n.a. n.a. DOI[10.1016/S0031-9422(02)00231-5]
NPO15592 Swertia punctata Species Gentianaceae Eukaryota n.a. n.a. n.a. PMID[12377236]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. PMID[20121165]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO15592 Swertia punctata Species Gentianaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO539 Picea vulgaris Species Pinaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO14062 Oophaga speciosa Species Dendrobatidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO16561 Viscum articulatum Species Viscaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT113 Cell Line RAW264.7 Mus musculus IC50 = 23400.0 nM PMID[553306]
NPT113 Cell Line RAW264.7 Mus musculus Activity = 88.7 % PMID[553306]
NPT1 Others Radical scavenging activity ED50 = 100.0 uM PMID[553306]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC236934 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC5778
0.9873 High Similarity NPC229687
0.9872 High Similarity NPC29830
0.9811 High Similarity NPC231194
0.9811 High Similarity NPC21190
0.9811 High Similarity NPC105095
0.9811 High Similarity NPC44328
0.9811 High Similarity NPC177731
0.9811 High Similarity NPC22195
0.9811 High Similarity NPC183357
0.9811 High Similarity NPC79056
0.9811 High Similarity NPC51326
0.981 High Similarity NPC45400
0.981 High Similarity NPC477502
0.981 High Similarity NPC229729
0.9809 High Similarity NPC22832
0.9809 High Similarity NPC311830
0.9808 High Similarity NPC127782
0.9808 High Similarity NPC300537
0.975 High Similarity NPC256760
0.975 High Similarity NPC261254
0.9748 High Similarity NPC270578
0.9748 High Similarity NPC43587
0.9748 High Similarity NPC209296
0.9748 High Similarity NPC472383
0.9748 High Similarity NPC112755
0.9748 High Similarity NPC471457
0.9748 High Similarity NPC293629
0.9748 High Similarity NPC95855
0.9748 High Similarity NPC210042
0.9748 High Similarity NPC472381
0.9748 High Similarity NPC170675
0.9748 High Similarity NPC52382
0.9748 High Similarity NPC195257
0.9747 High Similarity NPC115674
0.9747 High Similarity NPC210073
0.9745 High Similarity NPC222936
0.9745 High Similarity NPC309025
0.9745 High Similarity NPC270335
0.9745 High Similarity NPC243930
0.9745 High Similarity NPC19709
0.9745 High Similarity NPC284960
0.9745 High Similarity NPC88023
0.9745 High Similarity NPC191306
0.9689 High Similarity NPC208668
0.9689 High Similarity NPC239549
0.9689 High Similarity NPC51774
0.9689 High Similarity NPC236191
0.9688 High Similarity NPC78734
0.9688 High Similarity NPC34287
0.9688 High Similarity NPC474434
0.9688 High Similarity NPC44558
0.9688 High Similarity NPC471416
0.9688 High Similarity NPC150767
0.9686 High Similarity NPC93099
0.9686 High Similarity NPC160156
0.9686 High Similarity NPC92565
0.9684 High Similarity NPC165720
0.9682 High Similarity NPC189142
0.9682 High Similarity NPC473043
0.9682 High Similarity NPC77660
0.9627 High Similarity NPC48773
0.9627 High Similarity NPC472386
0.9627 High Similarity NPC235575
0.9627 High Similarity NPC205076
0.9627 High Similarity NPC267254
0.9627 High Similarity NPC301683
0.9627 High Similarity NPC307518
0.9625 High Similarity NPC226294
0.9625 High Similarity NPC219904
0.9625 High Similarity NPC223747
0.9625 High Similarity NPC120099
0.9625 High Similarity NPC86008
0.9625 High Similarity NPC201292
0.9625 High Similarity NPC183036
0.9625 High Similarity NPC58053
0.9625 High Similarity NPC475942
0.9625 High Similarity NPC45638
0.9625 High Similarity NPC105283
0.9625 High Similarity NPC186807
0.9625 High Similarity NPC93337
0.9625 High Similarity NPC225434
0.9625 High Similarity NPC469931
0.9625 High Similarity NPC105025
0.9625 High Similarity NPC203050
0.9623 High Similarity NPC197285
0.9623 High Similarity NPC8856
0.9623 High Similarity NPC21100
0.962 High Similarity NPC168822
0.962 High Similarity NPC88043
0.9618 High Similarity NPC182045
0.9568 High Similarity NPC204693
0.9565 High Similarity NPC67105
0.9565 High Similarity NPC206123
0.9565 High Similarity NPC285197
0.9565 High Similarity NPC105511
0.9565 High Similarity NPC212748
0.9565 High Similarity NPC224462
0.9565 High Similarity NPC218488
0.9565 High Similarity NPC95866
0.9563 High Similarity NPC173637
0.9563 High Similarity NPC84362
0.9563 High Similarity NPC52550
0.9563 High Similarity NPC226304
0.9563 High Similarity NPC58716
0.9563 High Similarity NPC116745
0.9563 High Similarity NPC127546
0.9563 High Similarity NPC265530
0.9563 High Similarity NPC317489
0.9563 High Similarity NPC146792
0.9563 High Similarity NPC45618
0.9563 High Similarity NPC325555
0.9563 High Similarity NPC223424
0.956 High Similarity NPC277205
0.956 High Similarity NPC284277
0.956 High Similarity NPC475366
0.956 High Similarity NPC475497
0.9554 High Similarity NPC110349
0.9512 High Similarity NPC241196
0.9509 High Similarity NPC198199
0.9509 High Similarity NPC108202
0.9509 High Similarity NPC102028
0.9509 High Similarity NPC476472
0.9509 High Similarity NPC294815
0.9509 High Similarity NPC19108
0.9509 High Similarity NPC220173
0.9509 High Similarity NPC142996
0.9509 High Similarity NPC294629
0.9509 High Similarity NPC473327
0.9509 High Similarity NPC16194
0.9506 High Similarity NPC33054
0.9506 High Similarity NPC203259
0.9506 High Similarity NPC471748
0.9506 High Similarity NPC259152
0.9506 High Similarity NPC67134
0.9506 High Similarity NPC176740
0.9506 High Similarity NPC47140
0.9506 High Similarity NPC476405
0.9506 High Similarity NPC254540
0.9506 High Similarity NPC156977
0.9506 High Similarity NPC26230
0.9506 High Similarity NPC153755
0.9506 High Similarity NPC172807
0.9506 High Similarity NPC180918
0.9506 High Similarity NPC155877
0.9506 High Similarity NPC211594
0.9506 High Similarity NPC471725
0.9506 High Similarity NPC60735
0.9506 High Similarity NPC3583
0.9506 High Similarity NPC117260
0.9506 High Similarity NPC134532
0.9503 High Similarity NPC61791
0.9503 High Similarity NPC227508
0.95 High Similarity NPC135599
0.95 High Similarity NPC145038
0.95 High Similarity NPC281131
0.95 High Similarity NPC56077
0.95 High Similarity NPC118284
0.95 High Similarity NPC99957
0.95 High Similarity NPC276222
0.95 High Similarity NPC181616
0.95 High Similarity NPC113968
0.95 High Similarity NPC274618
0.95 High Similarity NPC88789
0.95 High Similarity NPC308404
0.95 High Similarity NPC253662
0.95 High Similarity NPC179950
0.95 High Similarity NPC277174
0.95 High Similarity NPC73855
0.95 High Similarity NPC328940
0.9487 High Similarity NPC206378
0.9451 High Similarity NPC472380
0.9451 High Similarity NPC255799
0.9451 High Similarity NPC472384
0.9451 High Similarity NPC268533
0.9451 High Similarity NPC169733
0.9451 High Similarity NPC472382
0.9448 High Similarity NPC45522
0.9448 High Similarity NPC88560
0.9448 High Similarity NPC175230
0.9448 High Similarity NPC169977
0.9448 High Similarity NPC172033
0.9448 High Similarity NPC101026
0.9448 High Similarity NPC472993
0.9448 High Similarity NPC42773
0.9448 High Similarity NPC25724
0.9448 High Similarity NPC24043
0.9448 High Similarity NPC4390
0.9448 High Similarity NPC21666
0.9444 High Similarity NPC245014
0.9444 High Similarity NPC259896
0.9444 High Similarity NPC293004
0.9444 High Similarity NPC67326
0.9444 High Similarity NPC255157
0.9444 High Similarity NPC282987
0.9444 High Similarity NPC244776
0.9444 High Similarity NPC204937
0.9444 High Similarity NPC254855
0.9444 High Similarity NPC156869
0.9444 High Similarity NPC84265

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC236934 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9811 High Similarity NPD7074 Phase 3
0.9748 High Similarity NPD7054 Approved
0.9688 High Similarity NPD7472 Approved
0.9506 High Similarity NPD6797 Phase 2
0.9448 High Similarity NPD7251 Discontinued
0.9441 High Similarity NPD3818 Discontinued
0.939 High Similarity NPD7808 Phase 3
0.9317 High Similarity NPD6167 Clinical (unspecified phase)
0.9317 High Similarity NPD6168 Clinical (unspecified phase)
0.9317 High Similarity NPD6166 Phase 2
0.9304 High Similarity NPD4381 Clinical (unspecified phase)
0.9295 High Similarity NPD1934 Approved
0.9273 High Similarity NPD4338 Clinical (unspecified phase)
0.9114 High Similarity NPD2393 Clinical (unspecified phase)
0.903 High Similarity NPD7804 Clinical (unspecified phase)
0.8875 High Similarity NPD2801 Approved
0.8765 High Similarity NPD4868 Clinical (unspecified phase)
0.8704 High Similarity NPD3817 Phase 2
0.8688 High Similarity NPD4380 Phase 2
0.8662 High Similarity NPD1511 Approved
0.865 High Similarity NPD3882 Suspended
0.8647 High Similarity NPD6559 Discontinued
0.8553 High Similarity NPD1512 Approved
0.8494 Intermediate Similarity NPD5494 Approved
0.8485 Intermediate Similarity NPD7075 Discontinued
0.848 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8397 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8397 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD1549 Phase 2
0.8303 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8303 Intermediate Similarity NPD1465 Phase 2
0.8261 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8256 Intermediate Similarity NPD5844 Phase 1
0.8253 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8242 Intermediate Similarity NPD6801 Discontinued
0.8225 Intermediate Similarity NPD6959 Discontinued
0.8221 Intermediate Similarity NPD1653 Approved
0.8198 Intermediate Similarity NPD7228 Approved
0.8193 Intermediate Similarity NPD7819 Suspended
0.8182 Intermediate Similarity NPD7411 Suspended
0.8176 Intermediate Similarity NPD6232 Discontinued
0.816 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD5402 Approved
0.814 Intermediate Similarity NPD7473 Discontinued
0.8118 Intermediate Similarity NPD7199 Phase 2
0.8101 Intermediate Similarity NPD2796 Approved
0.8086 Intermediate Similarity NPD6799 Approved
0.8049 Intermediate Similarity NPD5403 Approved
0.8038 Intermediate Similarity NPD1510 Phase 2
0.8037 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8023 Intermediate Similarity NPD8313 Approved
0.8023 Intermediate Similarity NPD8312 Approved
0.8013 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8013 Intermediate Similarity NPD1613 Approved
0.8011 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8011 Intermediate Similarity NPD7685 Pre-registration
0.8 Intermediate Similarity NPD6234 Discontinued
0.7937 Intermediate Similarity NPD7266 Discontinued
0.7927 Intermediate Similarity NPD5401 Approved
0.7919 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD37 Approved
0.7904 Intermediate Similarity NPD6599 Discontinued
0.7901 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7898 Intermediate Similarity NPD1240 Approved
0.7886 Intermediate Similarity NPD3751 Discontinued
0.7882 Intermediate Similarity NPD4967 Phase 2
0.7882 Intermediate Similarity NPD4965 Approved
0.7882 Intermediate Similarity NPD4966 Approved
0.7874 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7866 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD3787 Discontinued
0.7833 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD3027 Phase 3
0.7799 Intermediate Similarity NPD1607 Approved
0.7785 Intermediate Similarity NPD943 Approved
0.7765 Intermediate Similarity NPD8455 Phase 2
0.776 Intermediate Similarity NPD8151 Discontinued
0.7756 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7749 Intermediate Similarity NPD7584 Approved
0.7736 Intermediate Similarity NPD1933 Approved
0.7714 Intermediate Similarity NPD3926 Phase 2
0.7713 Intermediate Similarity NPD6779 Approved
0.7713 Intermediate Similarity NPD6776 Approved
0.7713 Intermediate Similarity NPD6780 Approved
0.7713 Intermediate Similarity NPD6781 Approved
0.7713 Intermediate Similarity NPD6782 Approved
0.7713 Intermediate Similarity NPD6777 Approved
0.7713 Intermediate Similarity NPD6778 Approved
0.7709 Intermediate Similarity NPD7240 Approved
0.7692 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD919 Approved
0.7683 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7683 Intermediate Similarity NPD4628 Phase 3
0.7683 Intermediate Similarity NPD3750 Approved
0.7674 Intermediate Similarity NPD7768 Phase 2
0.7669 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.763 Intermediate Similarity NPD3749 Approved
0.7625 Intermediate Similarity NPD230 Phase 1
0.76 Intermediate Similarity NPD1247 Approved
0.7592 Intermediate Similarity NPD7435 Discontinued
0.7592 Intermediate Similarity NPD7696 Phase 3
0.7592 Intermediate Similarity NPD7698 Approved
0.7592 Intermediate Similarity NPD7697 Approved
0.759 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD7783 Phase 2
0.7547 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7546 Intermediate Similarity NPD2935 Discontinued
0.7546 Intermediate Similarity NPD1551 Phase 2
0.753 Intermediate Similarity NPD6190 Approved
0.7526 Intermediate Similarity NPD7701 Phase 2
0.7516 Intermediate Similarity NPD447 Suspended
0.7515 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2534 Approved
0.75 Intermediate Similarity NPD2532 Approved
0.75 Intermediate Similarity NPD2533 Approved
0.7461 Intermediate Similarity NPD7870 Phase 2
0.7461 Intermediate Similarity NPD7871 Phase 2
0.7448 Intermediate Similarity NPD6823 Phase 2
0.7447 Intermediate Similarity NPD6534 Approved
0.7447 Intermediate Similarity NPD6535 Approved
0.7435 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD7699 Phase 2
0.7421 Intermediate Similarity NPD7700 Phase 2
0.741 Intermediate Similarity NPD2800 Approved
0.741 Intermediate Similarity NPD6674 Discontinued
0.7396 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7382 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD3748 Approved
0.7368 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7363 Intermediate Similarity NPD5953 Discontinued
0.736 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD7874 Approved
0.7347 Intermediate Similarity NPD7585 Approved
0.7333 Intermediate Similarity NPD6100 Approved
0.7333 Intermediate Similarity NPD6099 Approved
0.7326 Intermediate Similarity NPD3226 Approved
0.7326 Intermediate Similarity NPD7458 Discontinued
0.7323 Intermediate Similarity NPD7801 Approved
0.732 Intermediate Similarity NPD7680 Approved
0.7312 Intermediate Similarity NPD4908 Phase 1
0.731 Intermediate Similarity NPD920 Approved
0.7308 Intermediate Similarity NPD1091 Approved
0.7296 Intermediate Similarity NPD7583 Approved
0.7283 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7282 Intermediate Similarity NPD8320 Phase 1
0.7282 Intermediate Similarity NPD8319 Approved
0.7273 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD7033 Discontinued
0.7263 Intermediate Similarity NPD4360 Phase 2
0.7263 Intermediate Similarity NPD4363 Phase 3
0.7256 Intermediate Similarity NPD6651 Approved
0.7253 Intermediate Similarity NPD7286 Phase 2
0.725 Intermediate Similarity NPD9494 Approved
0.7235 Intermediate Similarity NPD7390 Discontinued
0.7222 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7219 Intermediate Similarity NPD8434 Phase 2
0.7219 Intermediate Similarity NPD8150 Discontinued
0.7215 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD6212 Phase 3
0.7211 Intermediate Similarity NPD6213 Phase 3
0.7205 Intermediate Similarity NPD6832 Phase 2
0.7202 Intermediate Similarity NPD1243 Approved
0.7197 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7193 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD2798 Approved
0.7186 Intermediate Similarity NPD2346 Discontinued
0.7186 Intermediate Similarity NPD2344 Approved
0.7176 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD2799 Discontinued
0.716 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7127 Intermediate Similarity NPD5242 Approved
0.7126 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD1203 Approved
0.7119 Intermediate Similarity NPD5353 Approved
0.7117 Intermediate Similarity NPD2313 Discontinued
0.7117 Intermediate Similarity NPD6798 Discontinued
0.7111 Intermediate Similarity NPD8127 Discontinued
0.7102 Intermediate Similarity NPD6844 Discontinued
0.7101 Intermediate Similarity NPD1652 Phase 2
0.7101 Intermediate Similarity NPD5619 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7092 Intermediate Similarity NPD5005 Approved
0.7092 Intermediate Similarity NPD5006 Approved
0.7091 Intermediate Similarity NPD5124 Phase 1
0.7091 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.709 Intermediate Similarity NPD6842 Approved
0.709 Intermediate Similarity NPD6841 Approved
0.709 Intermediate Similarity NPD6843 Phase 3
0.7089 Intermediate Similarity NPD1610 Phase 2
0.7072 Intermediate Similarity NPD5711 Approved
0.7072 Intermediate Similarity NPD5710 Approved
0.7066 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7045 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD7930 Approved
0.7021 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7018 Intermediate Similarity NPD2309 Approved
0.7012 Intermediate Similarity NPD3268 Approved
0.7005 Intermediate Similarity NPD8155 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data